A Common Nonsynonymous Single Nucleotide Polymorphism in the SLC30A8 Gene Determines ZnT8 Autoantibody Specificity in Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Zinc transporter eight (SLC30A8) is a major target of autoimmunity in human type 1A diabetes and is implicated in type 2 diabetes in genome-wide association studies. The type 2 diabetes nonsynonymous single nucleotide polymorphism (SNP) affecting aa325 lies within the region of highest ZnT8 autoantibody (ZnT8A) binding, prompting an investigation of its relationship to type 1 diabetes. RESEARCH DESIGN AND METHODS—ZnT8A radioimmunoprecipitation assays were performed in 421 new-onset type 1 diabetic Caucasians using COOH-terminal constructs incorporating the known human aa325 variants (Trp, Arg, and Gln). Genotypes were determined by PCR-based SNP analysis. RESULTS—Sera from 224 subjects (53%) were reactive to Arg325 probes, from 185 (44%) to Trp325probes, and from 142 (34%) to Gln325probes. Sixty subjects reacted only with Arg325 constructs, 31 with Trp325 only, and 1 with Gln325 only. The restriction to either Arg325 or Trp325 corresponded with inheritance of the respective C- or T-alleles. A strong gene dosage effect was also evident because both Arg- and Trp-restricted ZnT8As were less prevalent in heterozygous than homozygous individuals. The SLC30A8 SNP allele frequency (75% C and 25% T) varied little with age of type 1 diabetes onset or the presence of other autoantibodies. CONCLUSIONS—The finding that diabetes autoimmunity can be defined by a single polymorphic residue has not previously been documented. It argues against ZnT8 autoimmunity arising from molecular mimicry and suggests a mechanistic link between the two major forms of diabetes. It has implications for antigen-based therapeutic interventions because the response to ZnT8 administration could be protective or immunogenic depending on an individual's genotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIG. 1. Relationship between autoantibody responses to Arg325, Trp325, and Gln325 constructs. A: Venn diagram illustrating the overlap of antibody detection with each of the polymorphic probes in the entire population (n = 421) in the study. The prevalence in each sector is expressed as a percentage of the population total. B–D: Assays were performed on the same set of 117 new-onset type 1 diabetic individuals and stratified as indicated; the numbers in each sector are shown in parentheses. The cutoff for positive responses was set at 0.05 (vertical and horizontal lines). Responses judged to be equivalent are set by the boundaries indicated by the angled lines, which correspond to a 3-SD excursion from the diagonal, assuming an intrassay coefficient of variation of 12.5% for each sample. Data are expressed as the immunoprecipitation index (sample-control)/(positive sample [BUNE]-control).](https://figures.cochat.ai/paper-figures/0d1ac58b771442ef8b3af5b2564a5c49/a-common-nonsynonymous-single-nucleotide-polymorphism-in-the-slc30a8-gene-figure-1.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Islet cell autoantibodies comprise autoantibodies to islet cell cytoplasm (ICA), to native insulin [referred to as “insulin autoantibodies” (IAA) ( 286 and IA-2bA (also known as phogrin) (291)], and to three variants of zinc transporter 8 (ZnT8A) (292,293).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [293]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993 · cited 1×
“The relationship between ZnT8 autoantibody reactivity and genetic variation at the SLC30A8 locus was examined using the SNP (rs13266634) encoding the Arg/Trp325 variant and two adjacent noncoding SNPs identified in a type 2 diabetes genome-wide association study (6), rs2466295, located 259 bp distally in the 3 UTR, an…”
MethodGenome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
Wenzlau, J. M., Juhl, K., Yu, L., Moua, O., Sarkar, S. A., Gottlieb, P., Rewers, M., Eisenbarth, G. S., Jensen, J., Davidson, H. W., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705894104 · Cited by 1,014
Self-citationDiabetes induced by Coxsackie virus: Initiation by bystander damage and not molecular mimicry
Horwitz, M. S., Bradley, L. M., Harbertson, J., Krahl, T., Lee, J., & Sarvennick, N. (1998) · Nature Medicine · doi:10.1038/nm0798-781 · Cited by 669
Environmental Triggers and Determinants of Type 1 Diabetes
Knip, M., Veijola, R., Virtanen, S. M., Hyöty, H., Vaarala, O., & Åkerblom, H. K. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s125 · Cited by 495
Chimienti, F., Devergnas, S., Favier, A., & Seve, M. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2330 · Cited by 470 · cited 1×
“It is encoded by SLC30A8, one of nine human genes for multispanning transmembrane proteins facilitating Zn(2) efflux from the cell and sequestration into intracellular compartments (4,5).”
BackgroundRewers, M., Bugawan, T. L., Norris, J. M., Blair, A., Beaty, B., Hoffman, M., McDuffie, R. S., Hamman, R. F., Klingensmith, G., Eisenbarth, G. S., et al. (1996) · Diabetologia · doi:10.1007/s001250050514 · Cited by 422 · cited 1×
“1% Hispanic) were parents and children in the Diabetes Autoimmunity Study in the Young (DAISY) general population cohort and parents of the sibling/offspring cohort (13).”
BackgroundSelf-citationA Novel Family of Ubiquitous Heavy Metal Ion Transport Proteins
Paulsen, I. T., & Jr., M. H. S. (1997) · Journal of Membrane Biology · doi:10.1007/s002329900192 · Cited by 392 · cited 1×
“The COOH-terminal domain of ZnT8 to which type 1 diabetes autoantibodies bind (3) incorporates a conserved protein fold found in the large family of cation diffusion facilitator efflux carriers and has orthologs in all cellular organisms (15).”
Background
Cited by
Items 101–200 of 205
Dunseath, G. J., Ananieva-Jordanova, R., Coles, R. L., Powell, M. J., Amoroso, M., Furmaniak, J., Smith, B. R., Dayan, C. M., & Luzio, S. D. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.05.010 · Cited by 26
“%) in Asian populations and only occurs in 2% of African Americans [6,7].”
BackgroundMethodInfluentialSørensen, J., Vaziri‐Sani, F., Maziarz, M., Kristensen, K., Ellerman, A., Breslow, N. E., Lernmark, Å., Pociot, F., Brorsson, C., & Birkebæk, N. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.12.013 · Cited by 23
“Zn T8 autoantibodies were reported to be more prevalent against the Arg325 and Trp325 than against Gln325 [4,5].”
BackgroundZn2+‐transporter‐8: A dual role in diabetes
Chistiakov, D. A., & Voronova, N. V. (2009) · BioFactors · doi:10.1002/biof.49 · Cited by 27
“ZnT-8 was also found to be a major self-antigen in T1D [6], and rs13266634 modulates ZnT-8 autoantibody specificity [7].”
BackgroundLong, A. E., Gillespie, K. M., Aitken, R. J., Goode, J. C., Bingley, P. J., & Williams, A. J. K. (2013) · Diabetes · doi:10.2337/db12-1468 · Cited by 23
“The C-allele (encoding ZnT8-325R) confers a minor risk of type 2 diabetes and has been associated with reduced insulin secretion (3), but no direct evidence that this polymorphism alters ZnT8 expression is available.”
BackgroundIslet Autoantibody Analysis: Radioimmunoassays
Wyatt, R. C., & Williams, A. J. K. (2015) · Methods in molecular biology · doi:10.1007/7651_2015_292 · Cited by 20
Islet autoantibodies in disease prediction and pathogenesis
Jia, X., Gu, Y., High, H., & Yu, L. (2019) · Diabetology International · doi:10.1007/s13340-019-00414-9 · Cited by 19
Self-citationNew autoantibody detection technologies yield novel insights into autoimmune disease
Burbelo, P. D., & OʼHanlon, T. P. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000107 · Cited by 19
“For example, T1D patients harboring R325 produce strong signals in the RBA, whereas Q325 or W325 variants react poorly [17].”
BackgroundPrevalence of zinc transporter 8 antibodies in gestational diabetes mellitus
Dereke, J., Nilsson, C., Landin‐Olsson, M., & Hillman, M. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03766.x · Cited by 20
Faccinetti, N. I., Guerra, L. L., Steinhardt, A. P., Iacono, R. F., Frechtel, G. D., Trifone, L., Poskus, E., Trabucchi, A., & Valdez, S. N. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0681 · Cited by 17
Williams, C. L., Aitken, R. J., Wilson, I. V., Mortimer, G., Long, A. E., Williams, A. J. K., The BOX Study Group, & Gillespie, K. M. (2022) · Diabetic Medicine · doi:10.1111/dme.14979 · Cited by 21
Sørgjerd, E. P., Skorpen, F., Kvaløy, K., Midthjell, K., & Grill, V. (2012) · Autoimmunity · doi:10.3109/08916934.2012.732132 · Cited by 17
“In childhood and adolescent diabetes the SNP variant rs13266634 of the gene SLC30A8 is documented to be a determinant of ZnT8A epitope specificity and binding [3].”
BackgroundWilliams, C. L., Marzinotto, I., Brigatti, C., Gillespie, K. M., The BOX Study Group, Wilson, I. S., Aitken, R. J., Megson, C., Ballav, C., Dutta, A. K., et al. (2023) · Clinical & Experimental Immunology · doi:10.1093/cei/uxad139 · Cited by 20
“Due to the presence of all ZnT8A specificities [16], the maximum AU derived from both monomeric RBA was used to compare Nluc-ZnT8 LIPS and RBA by Spearman’s rank correlation and Bland–Altman analysis.”
BackgroundMethodSkärstrand, H., Krupinska, E., Haataja, T., Vaziri‐Sani, F., Lagerstedt, J. O., & Lernmark, Å. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12448 · Cited by 17
Triple chimeric islet autoantigen IA2–ZnT8WR to facilitate islet autoantibody determination
Yu, L., Liu, Y., Miao, D., Wenzlau, J. M., Davidson, H. W., Hutton, J. C., & Eisenbarth, G. S. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.12.004 · Cited by 16
Self-citationDevelopment of a luciferase-based system for the detection of ZnT8 autoantibodies
Ustinova, J., Žusinaite, E., Utt, M., Metsküla, K., Reimand, K., Huchaiah, V., Merits, A., & Uibo, R. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.01.009 · Cited by 16
Rogowicz‐Frontczak, A., Piłaciński, S., Wyka, K., Wierusz‐Wysocka, B., & Zozulińska‐Ziółkiewicz, D. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.11.007 · Cited by 16
Zinc transporter 8 autoantibody in the diagnosis of type 1 diabetes in children
Rochmah, N., Faizi, M., & Windarti, S. W. (2020) · Korean Journal of Pediatrics · doi:10.3345/cep.2019.01221 · Cited by 15
Characterization of the human SLC30A8 promoter and intronic enhancer
Pound, L. D., Sarkar, S. A., Cauchi, S., Wang, Y., Oeser, J. K., Lee, C. E., Froguel, P., Hutton, J. C., & O’Brien, R. M. (2011) · Journal of Molecular Endocrinology · doi:10.1530/jme-11-0055 · Cited by 15
“This same variant is also associated with autoantibody epitope specificity changes in human type 1 diabetes (Wenzlau et al. 2008).”
BackgroundSelf-citationAssociation of Zinc Transporter-8 Autoantibody (ZnT8A) with Type 1 Diabetes Mellitus
Bhatty, A., Baig, S., Fawwad, A., Rubab, Z. E., Shahid, M. A., & Waris, N. (2020) · Cureus · doi:10.7759/cureus.7263 · Cited by 14
“Introduction Type 1 diabetes mellitus (T1DM) is characterized by autoimmune destruction of pancreatic β cells, the targets being autoantigens showing high expression and β-cell specificity [1].”
Michels, A. W., Jeffrey, J., & Eisenbarth, G. S. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-478-4_15 · Cited by 15
Self-citationKawasaki, E., Oikawa, Y., Okada, A., Kanatsuna, N., Kawamura, T., Kikuchi, T., Terasaki, J., Miura, J., Ito, Y., & Hanafusa, T. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13251 · Cited by 13
Song, C.-C., Wu, L., Chen, G., Lv, W.-H., Chen, S.-W., & Luo, Z. (2020) · Aquaculture · doi:10.1016/j.aquaculture.2020.735570 · Cited by 12
Fichna, M., Rogowicz‐Frontczak, A., Żurawek, M., Fichna, P., Gryczyńska, M., Zozulińska‐Ziółkiewicz, D., & Ruchała, M. (2016) · Endocrine · doi:10.1007/s12020-016-0916-7 · Cited by 15
“Remarkably, ZnT8A from individuals homozygous for the SLC30A8 genotypes are often limited to their respective ZnT8 isoform [14, 24].”
BackgroundZinc transporter 8 autoantibodies assessment in daily practice
Hussein, H., Ibrahim, F., Sobngwi, E., Gautier, J., & Boudou, P. (2016) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2016.06.008 · Cited by 13
Understanding Autoimmune Diabetes through the Prism of the Tri-Molecular Complex
Bettini, M. L., & Bettini, M. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00351 · Cited by 11
Neuropeptide Y is a minor autoantigen in newly diagnosed type 1 diabetes patients
Skärstrand, H., Vaziri‐Sani, F., Delli, A. J., Törn, C., Larsson, H. E., Ivarsson, S. A., Agardh, D., Lernmark, Å., & the Skåne study group (2014) · Pediatric Diabetes · doi:10.1111/pedi.12222 · Cited by 10
Genetic Polymorphisms and Zinc Status: Implications for Supplementation in Metabolic Diseases
Virgili, F., Ambra, R., McCormack, J. M., Simpson, E. E. A., Ciarapica, D., Barnaba, L., Azzini, E., & Polito, A. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612824666181016155903 · Cited by 11
“T2DM: Type 2 diabetes mellitus; T1DM: Type 1 diabetes mellitus 2.2.2.3 ZnT3 polymorphisms According to the NCBI database, 1103 validated SNPs are present in the human ZnT3 gene region.”
BackgroundInfluentialNovel enzyme-linked immunosorbent assay for bivalent ZnT8 autoantibodies
Kawasaki, E., Tanaka, M., Miwa, M., Abiru, N., & Kawakami, A. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0532-4 · Cited by 11
“Although we and others reported that there is a strong genetic specificity between the ZnT8A variants and the Slc30A8 gene SNPs [3,4], taken together these data highlight the different strength of humoral autoimmune response to the ZnT8 variants, which may be associated with the rate of β cell destruction.”
Type 1 (Insulin-Dependent) Diabetes Mellitus
Delli, A. J., & Lernmark, Å. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00039-1 · Cited by 12
Prevalence of Autoantibodies and HLA DR, DQ in Type 1 Diabetes Mellitus
Singh, S., Panihar, U., Singh, G., Agrawal, N. K., Singh, R. G., & Kumar, S. B. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/18657.8163 · Cited by 20
“, reported that 63% newly diagnosed T1DM and 3 % healthy control and 3% T2DM have ZnT8 Ab [26].”
BackgroundComplete loss of SLC30A8 in humans improves glucose metabolism and beta cell function
Lamarche, L. B., Koch, C., Khalid, S., Khan, M. Z., Zessis, R., Clement, M. E., Denning, D. P., Goldfine, A. B., Splawski, I., Abbasi, A., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06530-3 · Cited by 16
“We also included the common variant Arg325Trp, which has been reported in previous studies to be associated with lower glucose and T2D risk[4, 8-10, 12, 17, 20].”
Brønstad, I., Skinningsrud, B., Bratland, E., Løvås, K., Undlien, D. E., Husebye, E. S., & Wolff, A. S. B. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0432 · Cited by 11
Zinc Transport Proteins and Zinc Signaling
Kambe, T., Tsuji, T., & Fukue, K. (2014) · Springer eBooks · doi:10.1007/978-4-431-55114-0_3 · Cited by 12
Ingemansson, S., Vaziri‐Sani, F., Lindblad, U., Guðbjörnsdóttir, S., Törn, C., & on Behalf of the Diss-Study Group (2012) · Autoimmunity · doi:10.3109/08916934.2012.730585 · Cited by 9
“5%) using the SNP (rs13266634), have been identified coding for two different amino acids (two phenotypes) in position 325, namely, ZnT8-Arginine (ZnT8R) related to CC and ZnT8-Tryptophan related to TT [1].”
BackgroundMethodInfluentialDudek, N. L., & Purcell, A. W. (2014) · Vitamins and hormones · doi:10.1016/b978-0-12-800174-5.00005-3 · Cited by 10
HLA-DQA1 and HLA-DQB1 Gene Polymorphism in Indonesian Children with Type I Diabetes Mellitus
Soetjipto, Rochmah, N., Faizi, M., Hisbiyah, Y., & Endaryanto, A. (2022) · The Application of Clinical Genetics · doi:10.2147/tacg.s348115 · Cited by 8
Araújo, D. B., Skärstrand, H., Barone, B., Dantas, J. R., Kupfer, R., Zajdenverg, L., Milech, A., Vaziri‐Sani, F., de Oliveira, J. E. P., & Rodacki, M. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003088 · Cited by 9
“The autoantibody specificity of ZnT8RA and ZnT8WA, respectively, has been shown to be determined by the rs13266634 genotype (5,6).”
BackgroundWu, Q., Wang, X., Gu, Y., Zhang, X., Yao, Q., Chen, H., Xu, X., Yang, T., & Zhang, M. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-5077-7 · Cited by 9
“…influenced by a single amino acid at position 325 encoded as arginine or tryptophan in T1D, the ZnT8 C terminal dimer with Arg325Trp mutation protein has been proved to possess both specificity and sensitivity to detect ZnT8A (Kawasaki et al., 2014; Kawasaki et al., 2008; Wenzlau et al., 2008).”
BackgroundIs the NOD mouse a good model for type 1 diabetes?
Wong, F. S., Pearson, J. A., & Li, W. (2025) · Diabetologia · doi:10.1007/s00125-025-06579-0 · Cited by 8
Overview of microbial therapeutics in immunological disorders
Mishra, R., Mohanty, S., Mahapatra, S., & Prasad, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99336-4.00008-2 · Cited by 8
SLC30A8 Gene rs13266634 C/T Polymorphism in Children with Type 1 Diabetes in Tamil Nadu, India
Ramasamy, T., Asirvatham, A. J., Chitra, A., & Jayalakshmi, M. (2019) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2018.2018.0195 · Cited by 7
“11, encodes for the ZnT8 auto-antigen and comprises 369 amino acids (12,13).”
BackgroundLindbladh, I., Svärd, A. A., & Lernmark, Å. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00041-5 · Cited by 8
Zinc Transporters in Health and Disease
Kambe, T., Nishito, Y., & Fukue, K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802168-2.00023-3 · Cited by 11
Törn, C., Vaziri‐Sani, F., Ramelius, A., Larsson, H. E., Ivarsson, S. A., Amoroso, M., Furmaniak, J., Powell, M. J., & Smith, B. R. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01856-5 · Cited by 7
Prevalence of islet autoantibodies in Thai juvenile‐onset type 1 diabetes
Trisorus, C., Aroonparkmongkol, S., Kongmanas, H. B., & Sahakitrungruang, T. (2018) · Pediatrics International · doi:10.1111/ped.13687 · Cited by 7
Baumann, K., Kesselring, K., Lampasona, V., Walschus, U., Kerner, W., Waßmuth, R., & Schlosser, M. (2020) · Diabetic Medicine · doi:10.1111/dme.14389 · Cited by 6
Fuentes, S., Rodríguez, C. G., Rodríguez-Chacón, C., Toribio, R. G., Hermosín-Escudero, J., Pérez‐Pérez, A., & León‐Justel, A. (2023) · Laboratory Medicine · doi:10.1093/labmed/lmad079 · Cited by 8
Filchtinski, D., Kayser, J., Ettner, V., Holz, S., Kristensen, B. W., Schulte-Pelkum, J., Wilhelm, I., & Fiedler, R. (2025) · Journal of Immunological Methods · doi:10.1016/j.jim.2025.113885 · Cited by 6
Catapano, M. C., Parsons, D. S., Kotuniak, R., Mladěnka, P., Bal, W., & Maret, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062940 · Cited by 8
“The two ZnT8 variants are targeted by different autoantibodies in type 1 diabetes, indicating that the mutation also affects epitope formation, although there is no apparent change in type 1 diabetes risk [27].”
BackgroundAlshiekh, S., Larsson, H. E., Ivarsson, S. A., & Lernmark, Å. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch10 · Cited by 6
Method comparison of diabetes mellitus associated autoantibodies in serum specimens
Lenard, A., Rapp, A., Busch, S., & Findeisen, P. (2025) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2025-0137 · Cited by 4
Minerals in pregnancy and newborns
Hamdan, H. Z., Hassan, A. A., & Adam, I. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813862-5.00007-4 · Cited by 6
Novák, J., & Nováková, L. (2012) · Clinical and Experimental Medicine · doi:10.1007/s10238-012-0199-0 · Cited by 4
Latent Autoimmune Diabetes in Adults
Brooks‐Worrell, B., & Palmer, J. P. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-478-4_19 · Cited by 4
Shruthi, S., Mohan, V., Maradana, M. R., & Aravindhan, V. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.01.198 · Cited by 3
m6A‑SNP: From genetics to epigenetics (Review)
Niu, C.-X., & Zhou, R. (2022) · International Journal of Epigenetics · doi:10.3892/ije.2022.13 · Cited by 3
Prevalence of markers of beta cell autoimmunity and thyroid disease in children with coeliac disease
Légeret, C., Kutz, A., Jessica, B., Mundwiler, E., Köhler, H., & Bernasconi, L. (2023) · BMC Pediatrics · doi:10.1186/s12887-023-04294-6 · Cited by 5
“Literature confirms a higher prevalence of ZnT8 positive patients between 8 and 19 years [33, 34] at the very beginning of the auto-immune process.”
BackgroundType 1 Diabetes: Current Perspectives
Kozhakhmetova, A., & Gillespie, K. M. (2015) · Methods in molecular biology · doi:10.1007/7651_2015_289 · Cited by 4
“Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P et al (2007) The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.”
BackgroundSLC30A8: A Complex Road from Association to Function
Flannick, J. A., & Lowe, W. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-01574-3_18 · Cited by 2
IN DEBATE: THE PRIMARY CAUSE OF TYPE 1 DIABETES
Ionescu-Tirgoviste, C., Guja, C., Gagniuc, P. A., Davila, C., & Paulescu, N. (2014) · Cited by 2
Vandewalle, J., Desouter, A. K., der Auwera, B. J. R. V., Chapaza, K. B., Nobels, F. R. E., Abrams, P. J., Lebrethon, M.-C., Lapauw, B., Keymeulen, B., Gorus, F., et al. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42156 · Cited by 3
The Use of Proteomics to Dissect the Molecular Specificities of T Cells in Type 1 Diabetes
Dudek, N. L., & Purcell, A. W. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.s12-006 · Cited by 2
“Indeed immune responses to a number of proteins involved in the production and regulation of the secretory granule such as the zinc transport family member 8 [36], IA-2 and IA-2β [37,38] are well established.”
BackgroundDelli, A. J., Larsson, H. E., Ivarsson, S. A., Lernmark, Å., Kong, A. P. S., & Chan, J. C. N. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch9 · Cited by 2
Mohammed, I. M., Jwaziri, A. K., & Bakr, H. M. (2024) · Academic International Journal of Medical Sciences · doi:10.59675/m221 · Cited by 1
The Genetics of Type 1 Diabetes
Kathleen, M. (2011) · InTech eBooks · doi:10.5772/21924 · Cited by 1
“These antibodies are markers of ongoing autoimmune destruction (Bottatzo et al., 1985) and the best characterized are specific to the islet proteins insulin (Palmer et al., 1983), glutamic acid decarboxylase (GAD) (Baekkeskov et al., 1990), IA-2 ( Christie et al., 1994) and the zinc transporter ZnT8 (Wenzlau et al., 2…”
BackgroundRole of nutrient transporters in lifestyle-related diseases
Taketani, Y., Yamanaka-Okumura, H., Yamamoto, H., & Takeda, E. (2013) · The Journal of Physical Fitness and Sports Medicine · doi:10.7600/jpfsm.2.409 · Cited by 1
Guo, L., & Achenbach, P. (2008) · The Review of Diabetic Studies · doi:10.1900/rds.2008.5.171 · Cited by 1
Balke, E. M., Demeester, S., Lee, D., Gillard, P., Hilbrands, R., de Velde, U. V., der Auwera, B. J. R. V., Ling, Z., Roep, B. O., PIPELEERS, D. G., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4609-z · Cited by 1
Wenzlau, J. M., Sheridan, L., & Hutton, J. C. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-478-4_2 · Cited by 1
Self-citationAdvancing Autoantibody Detection: A Journey from Conventional to State-of-the-Art Methods
Acosta‐Ampudia, Y., Monsalve, D. M., & Ramı́rez-Santana, C. (2024) · Rheumatology (Bulgaria) · doi:10.35465/32.2.2024.pp21-33 · Cited by 1
“Furthermore, RBA has been employed for the quantification of specific anti - bodies against proinsulin and insulin [37] as well as antibodies targeting Znt8, another important autoan - tigen in T1D [38].”
Genetics of Type 2 Diabetes: From Candidate Genes to Genome-Wide Association Analysis
Brown, K. M., & Shuldiner, A. R. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_10 · Cited by 1
Faccinetti, N. I., Rovitto, B. D., Guerra, L. L., Sabljic, A. V., Iacono, R. F., Trifone, L., Poskus, E., Trabucchi, A., & Valdez, S. N. (2016) · Revista Argentina de Endocrinología y Metabolismo · doi:10.1016/j.raem.2016.09.001 · Cited by 1
Burek, C. L., Rose, N. R., Barbesino, G., Wang, J., Steck, A. K., Eisenbarth, G. S., Yu, L., Vincentiis, L. D., Ricciuti, A., Remigis, A. D., et al. (2016) · ASM Press eBooks · doi:10.1128/9781555818722.ch98 · Cited by 1
Self-citationThe grey zone between type 1 and type 2 diabetes : genetic aspects of diabetes in adults
Andersen, M. K. (2012) · Työväentutkimus Vuosikirja · Cited by 2
Semzezem, C. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2017.tde-05102017-114232 · Cited by 1
Complete loss of SLC30A8 in humans improves glucose metabolism and beta cell functionPreprint
Lamarche, L. B., Koch, C., Khalid, S., Zaman, M., Zessis, R., Clement, M. E., Denning, D. P., Goldfine, A. B., Abbasi, A., Harrow, J., et al. (2024) · medRxiv · doi:10.1101/2024.04.05.24305397 · Cited by 1
Andrade, L. J. D. O., de Oliveira, G. C. M., Rocha, R. M., Bittencourt, A. M. V., David, T. M., & de Oliveira, L. M. (2024) · medRxiv · doi:10.1101/2024.06.07.24308627 · Cited by 1
“9 Additionally, ZnT8 autoantibody levels have been shown to correlate with the progression of beta cell destruction, providing a potential biomarker for monitoring disease activity.”
Sun, C. (2014) · Figshare · Cited by 1
Zinc BiologyApproach from Zinc Transporters
Kambe, T. (2009)
Aspects of autoantibody epitopes in type 1 diabetes
Skärstrand, H. (2014) · Lund University Publications (Lund University)
Immunology of b-Cell Destruction 37
Lernmark, Å., & Torre, D. L. (2015)
Cloning and characterization of IA-2 specific autoantibodies in Type 1 diabetes
Johnson, C. (2016) · Research Portal (King's College London)
Autoantikörper gegen Zinktransporter ZnT8
Stöcker, W., & Krüger, C. (2019) · Springer Reference Medizin · doi:10.1007/978-3-662-48986-4_465
Zinc transporter 8 autoantibody (ZnT8A) by ELISA for diagnosing type 1 diabetes among Chinese people
Qiu, X., Cuili, N., Xiao, L., Jing, J., Mu, Z.-Y., & Liu, K. (2018) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-018-0637-y
“However, the ZnT8A prevalence increased with increasing age of onset to a plateau at 8–16 years and then fell [24].”
BackgroundSLC30A8 Gene rs13266634 C/T Polymorphism in Type 1 Diabetes Children of Tamil Nadu, India
Ramasamy, T., Joseph, A. A., Chitra, A., & Jayalakshmi, M. (2018) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.0195
“The rs13266634 C/T plays a susceptible role in the presence of impaired autoimmunity mediated βcell dysfunction which leads to T1D development (13).”
BackgroundNatural History of Type 1 Diabetes
Fourlanos, S., Harrison, L. C., & Colman, P. G. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-478-4_17
Xu, K., Lv, H. X., Zhang, J., Chen, H., He, Y., Shen, M., Qian, Y., Jiang, H., Dai, H., Zheng, S., et al. (2022) · Acta Diabetologica · doi:10.1007/s00592-021-01831-6
“Besides, prior studies showed that the SLC30A8 rs13266634 C > T variant was significantly associated with positivity for ZnT8A in T1D subjects [13], but varied little with age onset of T1D or the presence of other autoantibodies [10, 33].”
ResultBashir, A., Oram, R. A., & Wong, F. S. (2022) · doi:10.1093/med/9780198870197.003.0245
Current literature in diabetes
(2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.952
Immunology of β-Cell Destruction
Lernmark, Å., & Torre, D. L. (2014) · Springer eBooks · doi:10.1007/978-94-007-6884-0_18-2
Type 1 (Insulin-Dependent) Diabetes Mellitus
Delli, A. J., & Lernmark, Å. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00040-x
Immunology of β-Cell Destruction
Lernmark, Å., & Torre, D. L. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_18
Anand, V., Li, Y., Liu, B., Ghalwash, M. F., Koski, E., Ng, K., Dunne, J. L., Jönsson, J., Winkler, C., Knip, M., et al. (2021) · Diabetes Care · doi:10.2337/figshare.14384324.v3
Autoantikörper gegen Zinktransporter ZnT8
Stöcker, W., & Krüger, C. (2017) · Springer eBooks · doi:10.1007/978-3-662-49054-9_465-1
Anand, V., Li, Y., Liu, B., Ghalwash, M. F., Koski, E., Ng, K., Dunne, J. L., Jönsson, J., Winkler, C., Knip, M., et al. (2021) · doi:10.2337/figshare.14384324
Gressner, A. M., & Arndt, T. (2013) · Springer eBooks · doi:10.1007/978-3-642-12921-6_1
Andrade, L. J. D. O., de Oliveira, L. C. M., de Oliveira, G. C. M., Silva, C. P., & de Oliveira, L. M. (2023) · Research Square · doi:10.21203/rs.3.rs-3325148/v1 · Cited by 1
Akel, O., & Lernmark, Å. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch14 · Cited by 3
Assessment of Anti-Zinc Transporter Protein-8 Function in Adults with Type 1 Diabetes
Khaleel, Z. K., Al-yozbakee, Z. M., & Al-Hasso, I. K. (2025) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v8i2.1786 · Cited by 1
Metadata
- Authors
- Wenzlau, J. M., Liu, Y., Yu, L., Moua, O., Fowler, K. T., Rangasamy, S., Walters, J., Eisenbarth, G. S., Davidson, H. W., & Hutton, J. C.
- Affiliations
- University of Colorado Denver (US)
- Jiangsu Province Hospital (CN)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-10-01
- Volume
- 57
- Issue
- 10
- Pages
- 2693-2697
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2551679
- OpenAlex
- W2134857194
- Cited by
- 205
- References
- 24
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 7 · 2023: 9 · 2022: 8 · 2021: 5 · 2020: 7 · 2019: 10 · 2018: 10 · 2017: 10 · 2016: 12 · 2015: 14 · 2014: 16 · 2013: 12 · 2012: 23
- FWCI
- 10.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association (P30 DK57516)
- National Institutes of Health (NIH-R01, NIH R01 DK052068, DK052068, DK57516)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057516, P30 DK 57516, R01DK052068)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- SLC30A8, zinc transporter 8, ZnT8 autoantibodies, type 1 diabetes, type 2 diabetes, non-synonymous single nucleotide polymorphisms, autoantibody specificity, gene dosage effect, molecular mimicry, autoimmunity
- MeSH terms
- Zinc Transporter 8, Adolescent, Adult, Antibody Specificity, Autoantibodies, Child, Child, Preschool, Diabetes Mellitus, Type 1, Genotype, Humans, Infant, Middle Aged, Polymerase Chain Reaction, Polymorphism, Single Nucleotide, Cation Transport Proteins, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.